The point-of-care diagnostics market is predicting substantial growth during the forecast period of 2016-2024 with the rise in COVID-19 testing as a significant growth factor. Other factors supporting the growth of the point-of-care diagnostics market are the increased prevalence of infectious diseases such as tuberculosis, AIDS, etc. and the rising incidences of target conditions. The increasing demand for rapid diagnostics among the general populace is also assisting the growth of the point-of-care diagnostics market.

The need for making the healthcare sector more patient-centric is proving to be a beneficial factor for the increase in the growth rate of the point-of-care diagnostics market. The centralized testing process does not seem convenient for many patients as it involves frequent visits to the clinics to complete the entire assessment process. Point-of-care devices offer a much-needed helping hand for achieving the goal of a patient-centric approach. Thus, the point-of-care diagnostics market may experience a considerable spike in the growth rate during the forecast period.

The point-of-care diagnostics market stood at US$6.8bn in 2016 and is expected to reach US$ 11.7bn by the end of 2024 with a stellar CAGR of 6.9 percent across the forecast period according to the report by Transparency Market Research (TMR). 

point of care diagnostics market

COVID-19 Outbreak Prompting Fierce Demand for Point-Of-Care Diagnostics Kits

The clouds of the new coronavirus threat loom over the world and continue to create havoc in the lives of millions of people. As of now, no vaccine is available for controlling the deadly disease. Maximum testing and quick hospitalization are key components for flattening the curve. The point-of-care diagnostics devices form the crux of increased testing. Manufacturers in the point-of-care diagnostics market are focusing on developing novel technologies for maximum testing within a minimum period. The use of cutting-edge technologies enables the point-of-care diagnostic kits to target RdRp genes for detecting positive cases in as little as 5 minutes. CRISPR-based technologies are also helping the point-of-care diagnostics market in generating growth for the point-of-care diagnostics market to a great extent.

The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. Development and production in maximum numbers is the need of the hour. Therefore, quick FDA approvals are proving to be the cherry on the cake for the increase in the growth rate of the point-of-care diagnostics market.

Home Care to Become the New Norm

Because of the rising threat of SARS-CoV-2 transmission, the influx of patients to the clinics is likely to decline greatly. Thus, home care may gain considerable traction even after the lockdown. Eventually, smartphone-based point-of-care diagnostics is estimated to propel the growth rate. Innovations such as smartphones combined with a microfluidic chip for rapid testing results may bring tremendous growth opportunities for the point-of-care diagnostics market. Home-based glucose monitoring systems are also garnering good sales because of the launch of innovative and advanced monitoring technologies such as well as the frequent multiplication of diabetes cases across the globe. Also, patients with co-morbidities are more prone to fatality caused due to COVID-19. Therefore, these devices provide efficient diagnostics at home without feeling the need for a visit to the clinic for consultation.

Major players are placing their bets on the point-of-care diagnostics market through investments, mergers, acquisitions, joint ventures, and partnerships. An increase in medical and surgical procedures coupled with the advancement of new technologies makes the point-of-care diagnostics market a profitable option for investment. The soaring demand for point-of-care diagnostics market is predicted to boost the scale of investments in the point-of-care diagnostics market. Major players involved in the point-of-care diagnostics market are always engaged in discovering efficient and path-breaking products that prove to be a shining star in terms of diagnostics. In addition, inculcation of various technologies such as ultrasounds can prove to be a breeding ground for the point-of-care diagnostics market.

Furthermore, prevention of incidents such as testing results not obtained due to loss of samples during transportation, wrong sample collection, and wrong labeling makes point-of-care diagnostics as the most feasible option in terms of testing. Besides, point-of-care diagnostics avoid time-dependent changes caused by delays relating to sample transit. It also minimizes post-analytical errors caused by incorrect information transmission. Hence, these advantages can prove to be growth generators for the point-of-care diagnostics market.

Most of the point-of-care devices are precise, extremely sensitive, linear, and provide almost accurate results with the proficiency involved in laboratory-based results. Therefore, this aspect can prove as a growth accelerator for the point-of-care diagnostics market.

North America May Emerge As a Champion

The major regional segments in the point-of-care diagnostics market are North America, Asia Pacific, the Middle East and Africa, Europe, and Latin America. North America may continue to be the champion growth-seeker for the point-of-care diagnostics market because of aspects like early access for the availability of new technologies and advanced healthcare infrastructure. The rising cases of diabetes in the U.S. may also play a supporting role in boosting the growth of the point-of-care diagnostics market. Mini-growth enhancers like technology miniaturization, improved portability, and lower system cost will further benefit the point-of-care diagnostics market in North America.

Developing regions such as India and China may also record substantial growth for the point-of-care diagnostics market. Increasing demand for precise and efficient diagnostics as well as the growing middle-class population with frequent health problems may prove as game-changing factors for fuelling growth rates across the forecast period. Further, lifestyle changes in combination with rising disposable income may also invite good growth for the point-of-care diagnostics market in Asia Pacific region.

Global Point-of-care Diagnostics Market: Overview

Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt clinical decision regarding patient management. The report on point-of-care diagnostics market, analyzes the current and future prospects of the market. The report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by geography, in terms of revenue %, for 2015.

Global Point-of- care Diagnostics Market: Drivers and Restraints

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the point-of-care diagnostics market, along with porter’s analysis, value chain analysis, of the global market, has been provided in this report. Market revenue and volume analysis for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc. Pricing analysis, for every region has been provided considering the average selling prices (ASP), of products, in these regions.

This report provides in-depth analysis of the point-of-care diagnostics market. The stakeholders for this report include companies involved in the manufacturing of Point-of-care Diagnostics. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and Market share analysis is analyzed to signify percentage share of the major players operating in the point-of-care diagnostics market. Furthermore, the report includes market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

Global Point-of-care Diagnostics Market: Research Methodology

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of key opinion leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.  

Global Point-of-care Diagnostics Market: Segmentation

Based on product type, the point-of-care diagnostics market has been segmented into Lateral flow assay test, Flow- through test, Solid phase assay test, Agglutination assay test. Based on applications, the point-of-care diagnostics market are segmented into Infectious Disease test, Cholesterol monitoring, Substance abuse test, Fertility & Pregnancy test, Blood Glucose Test. Based on end users, the market is segmented as hospitals, clinics, homecare settings and diagnostic centers. 

Global Point-of-care Diagnostics Market: Regional Outlook

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, Spain, rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, Rest of Middle East & Africa. The report also comprises list of major players in the market, their SWOT analysis, market share of these players in the Point-of-care Diagnostics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Alere Inc., Abbott Laboratories, Becton, Dickinson & Company, F. Hoffmann La Roche Ltd., Bio-Rad Laboratories, Inc. and Trinity Biotech among others.

The Point-of-care Diagnostics market has been segmented as follows:

Point-of-care Diagnostics Market, by Product Type

  • Lateral flow assay test
  • Flow- through test
  • Solid phase assay test
  • Agglutination assay test

Point-of-care Diagnostics Market, by Application

  • Infectious Disease Test
  • Cholesterol monitoring
  • Substance abuse Test
  • Fertility & Pregnancy Test
  • Blood Glucose Test

Point-of-care Diagnostics Market, by End Users

  • Hospitals
  • Clinics
  • Homecare Settings
  • Diagnostic Centers

Point-of-care Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Section 1: Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2: Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3: Executive Summary
3.1 Global Point-of-Care Diagnostics: Market Snapshot
3.2 Global Market Share Analysis by Region, 2015
3.3 Global Point-of-care Diagnostic Market: Opportunity Map

Section 4: Market Overview
4.1 Product Overview
4.2 Global Point-of-care Diagnostic Market: Key Industry Developments

Section 5: Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Growing prevalence of lifestyle diseases
      5.2.2 Early and Instant Diagnosis
      5.2.3 Ease of access
      5.2.4 Technological Innovations
      5.2.5 National and International collaborations 
      5.2.6 Convenience over bulky diagnostic equipment
      5.2.7 Cost effectiveness
5.3 Restraints
      5.3.1 Quantification is not possible
      5.3.2 Accuracy Issue
      5.3.3 Inability for multiple screening
      5.3.4 Limited End Point Stability
5.4 Opportunities
5.5 Porters Analysis
5.6 Value Chain Analysis 
5.7 Point-of-care Diagnostic Market Outlook

Section 6: Point-of-care Diagnostic Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 Global Point-of-care Diagnostic Market Value Share Analysis, by Product Type
6.4 Point-of-care Diagnostic Market Forecast, by Product Type 
6.5 Point-of-care Diagnostic Market Analysis, by Product Type 
      6.5.1 Lateral flow assay test
      6.5.2 Flow- through test
      6.5.3 Solid phase assay test
      6.5.4 Agglutination assay test
6.6 Point-of-care Diagnostic Market Attractiveness Analysis by Product Type
6.7 Key Trends

Section 7: Point-of-care Diagnostic Market Analysis, by Application
7.1 Key Findings
7.2 Introduction
7.3 Global Point-of-care Diagnostic Market Value Share Analysis, by Application Type
7.4 Point-of-Care Diagnostics Market Forecast, by Application Type 
7.5 Point-of-Care Diagnostics Market Analysis, by Application Type 
      7.5.1 Infectious Disease test
      7.5.2 Cholesterol monitoring
      7.5.3 Substance abuse test
      7.5.4  Fertility & Pregnancy test
      7.5.5  Blood Glucose Test
7.6 Point-of-care Diagnostic Market Attractiveness Analysis By Application Type
7.7 Key Trends 

Section 8: Point-of-care Diagnostic Market Analysis, by End Users
8.1 Key Findings
8.2 Introduction
8.3 Global Point-of-care Diagnostic Market Value Share Analysis, by End Users
8.4 Point-of-care Diagnostic Market Forecast, by End Users
8.5 Point-of-care Diagnostic Market Analysis, by End Users
      8.5.1 Hospitals
      8.5.2 Clinics
      8.5.3 Homecare Settings
      8.5.4 Diagnostics Centers
8.6 Point-of-care Diagnostic Market Attractiveness Analysis by End Users
8.7 Key Trends 

Section 9: Point-of-care Diagnostic Market Analysis, by Region
9.1 Global Point-of-care Diagnostic Market Snapshot, by Country
9.2 Global Point-of-care Diagnostic Market Value Share Analysis, by Region
9.3 Point-of-care Diagnostic Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10: North America Point-of-care Diagnostic Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, By Country
      10.3.1 North America Market Value Share Analysis, By Country
      10.3.2 North America Market Forecast by Country
10.4 Market Analysis, By Product Type
      10.4.1 North America Market Value Share Analysis, By Product Type
      10.4.2 North America Market Forecast by Product Type
10.5 Market Analysis, By Application
      10.5.1 North America Market Value Share Analysis, By Application
      10.5.2 North America Market Forecast by Application
10.6 Market Analysis, By End Users
      10.6.1 North America Market Value Share Analysis, By End Users
      10.6.2 North America Market Forecast by End Users
10.7 North America Market Attractiveness Analysis
      10.7.1 By Product Type
      10.7.2 By Application
      10.7.3 By End Users

Section 11: Europe Point-of-care Diagnostic Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Market Analysis, By Country
      11.3.1 Europe Market Value Share Analysis, By Country
      11.3.2 Europe Market Forecast by Country
11.4 Market Analysis, By Product Type
      11.4.1 Europe Market Value Share Analysis, By Product Type
      11.4.2 Europe Market Forecast by Product Type
11.5 Market Analysis, By Application
      11.5.1 Europe Market Value Share Analysis, By Application
      11.5.2 Europe Market Forecast by Application
11.6 Market Analysis, By End Users
      11.6.1 Europe Market Value Share Analysis, By End Users
      11.6.2 Europe Market Forecast by End Users
11.7 Europe Market Attractiveness Analysis
      11.7.1 By Product Type
      11.7.2 By Application
      11.7.3 By End Users

Section 12: Asia Pacific Point-of-care Diagnostic Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, By Country
      12.3.1 Asia Pacific Market Value Share Analysis, By Country
      12.3.2 Asia Pacific Market Forecast by Country
12.4 Market Analysis, By Product Type
      12.4.1 Asia Pacific Market Value Share Analysis, By Product Type
      12.4.2 Asia Pacific Market Forecast by Product Type
12.5 Market Analysis, By Application
      12.5.1 Asia Pacific Market Value Share Analysis, By Application
      12.5.2 Asia Pacific Market Forecast by Application
12.6 Market Analysis, By End Users
      12.6.1 Asia Pacific Market Value Share Analysis, By End Users
      12.6.2 Asia Pacific Market Forecast by End Users
12.7 Asia Pacific Market Attractiveness Analysis
      12.7.1 By Product Type
      12.7.2 By Application
      12.7.3 By End Users

Section 13: Latin America Point-of-care Diagnostic Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, By Country
      13.3.1 Latin America Market Value Share Analysis, by Country
      13.3.2 Latin America Market Forecast by Country
13.4 Market Analysis, By Product Type
      13.4.1 Latin America Market Value Share Analysis, By Product Type
      13.4.2 Latin America Market Forecast by Product Type
13.5 Market Analysis, By Application
      13.5.1 Latin America Market Value Share Analysis, By Application
      13.5.2 Latin America Market Forecast by Application
13.6 Market Analysis, By End Users
      13.6.1 Latin America Market Value Share Analysis, By End Users
      13.6.2 Latin America Market Forecast by End Users
13.7 Latin America Market Attractiveness Analysis
      13.7.1 By Product Type
      13.7.2 By Application
      13.7.3 By End Users

Section 14: Middle East & Africa Point-of-care Diagnostic Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, By Country
      14.3.1 Middle East & Africa Market Value Share Analysis, By Country
      14.3.2 Middle East & Africa Market Forecast by Country
14.4 Market Analysis, By Product Type
      14.4.1 Middle East & Africa Market Value Share Analysis, By Product Type
      14.4.2 Middle East & Africa Market Forecast by Product Type
14.5 Market Analysis, By Application
      14.5.1 Middle East & Africa Market Value Share Analysis, By Application
      14.5.2 Middle East & Africa Market Forecast by Application
14.6 Market Analysis, By End Users
      14.6.1 Middle East & Africa Market Value Share Analysis, By End Users
      14.6.2 Middle East & Africa Market Forecast By End Users
14.7 Middle East & Africa Market Attractiveness Analysis
      14.7.1 By Product Type
      14.7.2 By Application
      14.7.3 By End Users

Section 15: Company Profiles
15.1 Global Point-of-care Diagnostic Market Share Analysis by Company 
15.2 Competition Matrix
15.3 Company Profiles
      15.3.1 Abbott Laboratories
               15.3.1.1 Company Overview
               15.3.1.2 Business Overview
               15.3.1.3 Financial Overview
               15.3.1.4 SWOT Analysis
               15.3.1.5 Strategic Overview
      15.3.2 Becton Dickinson & Co.
               15.3.2.1 Company Overview
               15.3.2.2 Business Overview
               15.3.2.3 Financial Overview
               15.3.2.4 SWOT Analysis
               15.3.2.5 Strategic Overview
      15.3.3 Bio-Rad Laboratories, Inc.
               15.3.3.1 Company Overview
               15.3.3.2 Business Overview
               15.3.3.3 Financial Overview
               15.3.3.4 SWOT Analysis
               15.3.3.5 Strategic Overview
      15.3.4 Trinity Biotech
               15.3.4.1 Company Overview
               15.3.4.2 Business Overview
               15.3.4.3 Financial Overview
               15.3.4.4 SWOT Analysis
               15.3.4.5 Strategic Overview
      15.3.5 Alere Inc.
               15.3.5.1 Company Overview
               15.3.5.2 Business Overview
               15.3.5.3 Financial Overview
               15.3.5.4 SWOT Analysis
               15.3.5.5 Strategic Overview
      15.3.6 Danaher
               15.3.6.1 Company Overview
               15.3.6.2 Business Overview
               15.3.6.3 Financial Overview
               15.3.6.4 SWOT Analysis
               15.3.6.5 Strategic Overview
      15.3.7 F. Hoffmann-La Roche Ltd
               15.3.7.1 Company Overview
               15.3.7.2 Business Overview
               15.3.7.3 Financial Overview
               15.3.7.4 SWOT Analysis
               15.3.7.5 Strategic Overview
      15.3.8 Abaxis
               15.3.8.1 Company Overview
               15.3.8.2 Business Overview
               15.3.8.3 Financial Overview
               15.3.8.4 SWOT Analysis
               15.3.8.5 Strategic Overview

List of Tables

Table 01: Global Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Product Type, 2014–2024
Table 02: Global Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 03: Global Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by End-user, 2014–2024
Table 04: Global Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Region, 2014–2024
Table 05: North America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Country, 2014–2024
Table 06: North America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 07: North America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 08: North America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 09: Europe Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Country, 2014–2024
Table 10: Europe Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 11: Europe Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 12: Europe Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 13: Asia Pacific Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Country, 2014–2024
Table 14: Asia Pacific Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 15: Asia Pacific Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 16: Asia Pacific Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 17: Latin America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Country, 2014–2024
Table 18: Latin America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 19: Latin America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 20: Latin America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014-2024
Table 21: MEA Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Country, 2015–2024
Table 22: Middle East & Africa Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Product Type, 2014–2024
Table 23: Middle East & Africa Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by Application, 2014–2024
Table 24: Middle East & Africa Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, by End-user, 2014–2024

List of Figures
Figure 01: Global Point-of-care Diagnostic Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 02: Global Lateral flow assay Test Market Revenue (US$ Mn) and Volume (Thousand Units), 2014–2024
Figure 03: Global Flow-through Test Market Revenue 
Figure 04: Global Solid phase assay Test Market Revenue (US$ Mn) and Volume (Thousand Units), 2014– 2024
Figure 05: Global Agglutination assay Test Market Revenue (US$ Mn) and Volume (Thousand Units), 2014–2024
Figure 06: Point-of-care Diagnostic Market Attractiveness Analysis, by Product Type, 2015
Figure 05: highlights market share, CAGR, and absolute growth index of the global Point-of-care Diagnostic market by each product and its relative market attractiveness
Figure 07: Global Point-of-care Diagnostic Market Value Share Analysis, by Application, 2015 and 2024
Figure 08: Global Infectious Disease Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 09: Global Cholesterol Monitoring Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Substance Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Fertility and Pregnancy Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Blood Glucose Testing Market Revenue
Figure 13: Point-of-care Diagnostic Market Attractiveness Analysis, by Application, 2015
Figure 14: Global Point-of-care Diagnostic Market Value Share Analysis, by End-user, 2015 and 2024
Figure 15: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 16: Global Clinics Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 17: Global Home Care Settings Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 18: Global Diagnostic Centers Market Revenue
Figure 19: Point-of-care Diagnostic Market Attractiveness Analysis, by End-user, 2015
Figure 20: Global Point-of-care Diagnostic Market Value Share Analysis, by Region, 2015 and 2024
Figure 21: Point-of-care Diagnostic Market Attractiveness Analysis, by Region, 2015
Figure 22: North America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014–2024
Figure 23: North America Market Attractiveness Analysis,
Figure 24: North America Market Value Share Analysis, by Country, 2015 and 2024
Figure 25: North America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 26: North America Market Value Share Analysis, by Application, 2015 and 2024
Figure 27: North America Market Value Share Analysis, by End-user, 2015 and 2024
Figure 28: North America Market Attractiveness Analysis, by Product Type, 2015
Figure 29: North America Market Attractiveness Analysis, by Application, 2015
Figure 30: North America Market Attractiveness Analysis, by End-user, 2015
Figure 31: Europe Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014–2024
Figure 32: Europe Market Attractiveness Analysis, by Country, 2015
Figure 33: Europe Market Value Share Analysis, by Country,
Figure 34: Europe Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 35: Europe Market Value Share Analysis, by Application, 2015 and 2024
Figure 36: Europe Market Value Share Analysis, by End-user, 2015 and 2024
Figure 37: Europe Market Attractiveness Analysis, by Product Type, 2015
Figure 38: Europe Market Attractiveness Analysis, by Application, 2015
Figure 39: Europe Market Attractiveness Analysis, by End-user, 2015
Figure 40: Asia Pacific Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Thousand Units) Forecast, 2014–2024
Figure 41: Asia Pacific Market Attractiveness Analysis, by Country, 2015
Figure 42: Asia Pacific Market Value Share Analysis, by Country, 2015 and 2024
Figure 43: Asia Pacific Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 44: Asia Pacific Market Value Share Analysis, by Application, 2015 and 2024
Figure 45: Asia Pacific Market Value Share Analysis, by End-user, 2015 and 2024
Figure 46: Asia Pacific Market Attractiveness Analysis, by Product Type, 2015
Figure 47: Asia Pacific Market Attractiveness Analysis, by Application, 2015
Figure 48: Asia Pacific Market Attractiveness Analysis, by End-user, 2015
Figure 49: Latin America Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Units) Forecast, 2015–2024
Figure 50: Latin America Market Attractiveness Analysis, by Country, 2015
Figure 51: LATAM Market Value Share Analysis, by Country,
Figure 52: Latin America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 53: Latin America Market Value Share Analysis, by Application, 2015 and 2024
Figure 54: Latin America Market Value Share Analysis, by End-user, 2015 and 2024
Figure 55: Latin America Market Attractiveness Analysis, by Product Type, 2015
Figure 56: Latin America Market Attractiveness Analysis, by Application, 2015
Figure 57: Latin America Market Attractiveness Analysis, by End-user, 2015
Figure 58: MEA Point-of-care Diagnostic Market Size (US$ Mn) and Volume (Units) Forecast, 2015–2024
Figure 59: MEA Market Attractiveness Analysis, by Country, 2015
Figure 60: MEA Market Value Share Analysis, by Country, 2015 and 2024
Figure 61: MEA Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 62: Middle East & Africa Market Value Share Analysis, by Application, 2015 and 2024
Figure 63: Middle East & Africa Market Value Share Analysis, by End-user, 2015 and 2024
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2015
Figure 65: Middle East & Africa Market Attractiveness Analysis, by Application, 2015
Figure 66: Middle East & Africa Market Attractiveness Analysis, by End-user, 2015
Figure 67: Global Point-of-care Diagnostic Market Share Analysis By Company (2015)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Care Diagnostics Market